134 related articles for article (PubMed ID: 26486735)
1. Multinucleation is an objective feature useful in the diagnosis of pleomorphic lobular carcinoma in situ.
Blanco LZ; Thurow TA; Mahajan A; Susnik B; Helenowski I; Chmiel JS; Sullivan ME
Am J Clin Pathol; 2015 Nov; 144(5):722-6. PubMed ID: 26486735
[TBL] [Abstract][Full Text] [Related]
2. Evaluating agreement, histological features, and relevance of separating pleomorphic and florid lobular carcinoma in situ subtypes.
Singh K; Paquette C; Kalife ET; Wang Y; Mangray S; Quddus MR; Steinhoff MM
Hum Pathol; 2018 Aug; 78():163-170. PubMed ID: 29753007
[TBL] [Abstract][Full Text] [Related]
3. Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma.
Shamir ER; Chen YY; Krings G
Mod Pathol; 2020 Jun; 33(6):1078-1091. PubMed ID: 31907376
[TBL] [Abstract][Full Text] [Related]
4. Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast.
Chen YY; Hwang ES; Roy R; DeVries S; Anderson J; Wa C; Fitzgibbons PL; Jacobs TW; MacGrogan G; Peterse H; Vincent-Salomon A; Tokuyasu T; Schnitt SJ; Waldman FM
Am J Surg Pathol; 2009 Nov; 33(11):1683-94. PubMed ID: 19701073
[TBL] [Abstract][Full Text] [Related]
5. Descriptive study comparing outcomes of classic and nonclassic lobular carcinoma in situ (florid and pleomorphic) initially diagnosed on core needle biopsy.
Singh K; Sung CJ; Quddus MR
Breast J; 2020 Dec; 26(12):2350-2356. PubMed ID: 33047861
[TBL] [Abstract][Full Text] [Related]
6. Pleomorphic lobular carcinoma in situ (PLCIS) on breast core needle biopsies: clinical significance and immunoprofile.
Chivukula M; Haynik DM; Brufsky A; Carter G; Dabbs DJ
Am J Surg Pathol; 2008 Nov; 32(11):1721-6. PubMed ID: 18769331
[TBL] [Abstract][Full Text] [Related]
7. Pleomorphic and Florid Lobular Carcinoma In Situ Variants of the Breast: A Clinicopathologic Study of 85 Cases With and Without Invasive Carcinoma From a Single Academic Center.
Shamir ER; Chen YY; Chu T; Pekmezci M; Rabban JT; Krings G
Am J Surg Pathol; 2019 Mar; 43(3):399-408. PubMed ID: 30489319
[TBL] [Abstract][Full Text] [Related]
8. The florid subtype of lobular carcinoma in situ: marker or precursor for invasive lobular carcinoma?
Bagaria SP; Shamonki J; Kinnaird M; Ray PS; Giuliano AE
Ann Surg Oncol; 2011 Jul; 18(7):1845-51. PubMed ID: 21287281
[TBL] [Abstract][Full Text] [Related]
9. Pleomorphic Lobular Carcinoma In Situ: Imaging Features, Upgrade Rate, and Clinical Outcomes.
Savage JL; Jeffries DO; Noroozian M; Sabel MS; Jorns JM; Helvie MA
AJR Am J Roentgenol; 2018 Aug; 211(2):462-467. PubMed ID: 29894223
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin immunohistochemistry in breast pathology: uses and pitfalls.
Canas-Marques R; Schnitt SJ
Histopathology; 2016 Jan; 68(1):57-69. PubMed ID: 26768029
[TBL] [Abstract][Full Text] [Related]
11. Morphometric Analysis in the Diagnosis of Low-Grade Ductal and Lobular Carcinoma in Situ of the Breast.
Parra-Herran C; Hope T; Rashed T; Slodkowska E; Lu FI; Nofech-Mozes S
Anal Quant Cytopathol Histpathol; 2015 Dec; 37(6):331-8. PubMed ID: 26860008
[TBL] [Abstract][Full Text] [Related]
12. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases.
Sneige N; Wang J; Baker BA; Krishnamurthy S; Middleton LP
Mod Pathol; 2002 Oct; 15(10):1044-50. PubMed ID: 12379750
[TBL] [Abstract][Full Text] [Related]
13. Pleomorphic LCIS what do we know? A UK multicenter audit of pleomorphic lobular carcinoma in situ.
Masannat YA; Husain E; Roylance R; Heys SD; Carder PJ; Ali H; Maurice Y; Pinder SE; Sawyer E; Shaaban AM
Breast; 2018 Apr; 38():120-124. PubMed ID: 29310036
[TBL] [Abstract][Full Text] [Related]
14. Pleomorphic lobular carcinoma in situ of the breast: a single institution experience with clinical follow-up and centralized pathology review.
De Brot M; Koslow Mautner S; Muhsen S; Andrade VP; Mamtani A; Murray M; Giri D; Sakr RA; Brogi E; King TA
Breast Cancer Res Treat; 2017 Sep; 165(2):411-420. PubMed ID: 28612228
[TBL] [Abstract][Full Text] [Related]
15. Lobular neoplasia of the breast: an update.
Contreras A; Sattar H
Arch Pathol Lab Med; 2009 Jul; 133(7):1116-20. PubMed ID: 19642738
[TBL] [Abstract][Full Text] [Related]
16. Pleomorphic Lobular Carcinoma In Situ: Radiologic-Pathologic Features and Clinical Management.
Flanagan MR; Rendi MH; Calhoun KE; Anderson BO; Javid SH
Ann Surg Oncol; 2015 Dec; 22(13):4263-9. PubMed ID: 25893410
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and clinical outcomes of pleomorphic lobular carcinoma in situ of the breast.
Fasola CE; Chen JJ; Jensen KC; Allison KH; Horst KC
Breast J; 2018 Jan; 24(1):66-69. PubMed ID: 28929550
[TBL] [Abstract][Full Text] [Related]
18. Morphologic subtypes of lobular carcinoma in situ diagnosed on core needle biopsy: clinicopathologic features and findings at follow-up excision.
Kuba MG; Murray MP; Coffey K; Calle C; Morrow M; Brogi E
Mod Pathol; 2021 Aug; 34(8):1495-1506. PubMed ID: 33824462
[TBL] [Abstract][Full Text] [Related]
19. Lobular carcinoma in situ and infiltrating ductal carcinoma: frequent presence of DCIS as a precursor lesion.
Maluf H; Koerner F
Int J Surg Pathol; 2001 Apr; 9(2):127-31. PubMed ID: 11484500
[TBL] [Abstract][Full Text] [Related]
20. Invasive Lobular Carcinoma Mimicking Papillary Carcinoma: A Report of Three Cases.
Rakha EA; Abbas A; Sheeran R
Pathobiology; 2016; 83(5):221-7. PubMed ID: 27116593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]